Epidemic Pleurodynia: Symptoms, Causes, and Treatment

Epidemic pleurodynia, also known as Bornholm disease or devil’s grip, is a contagious viral infection that causes sudden and severe pain in the chest or upper abdomen, typically accompanied by flu-like symptoms. This condition is caused by enteroviruses, most commonly the Coxsackie B virus, and affects individuals of all ages, though it is most prevalent in children and young adults. While the condition can be uncomfortable and cause significant distress, it is not life-threatening and typically resolves within a few weeks with appropriate supportive care.

The disease earned its alternative name, Bornholm disease, from an outbreak that occurred on the Danish island of Bornholm in the Baltic Sea, which was one of the first well-documented cases of this condition. Understanding the characteristics, transmission, symptoms, and treatment options for epidemic pleurodynia is essential for recognizing the condition early and managing it effectively.

What Is Epidemic Pleurodynia?

Epidemic pleurodynia is a viral myalgia condition—a complication arising from specific viral infections—that primarily affects the muscles in the chest and upper abdomen. The condition is characterized by the inflammation of these muscles, which leads to the distinctive sharp, stabbing pain that defines the illness. Unlike many cardiac conditions that cause chest pain, epidemic pleurodynia is not related to heart disease and poses no life-threatening risk to patients.

The term “epidemic” refers to the tendency of this condition to occur in outbreaks, particularly during certain seasons when the responsible viruses are more prevalent in the population. The condition occurs when enteroviruses invade the body and specifically target the skeletal muscles of the thoracic and abdominal regions, causing inflammation and the characteristic pleuritic pain.

Causes of Epidemic Pleurodynia

Epidemic pleurodynia is caused by viral infections from the enterovirus family, with several specific viruses being responsible for the majority of cases. Understanding these causative agents is important for diagnosis and management.

Causative Viruses

The primary causative agents of epidemic pleurodynia include:

– Coxsackievirus B (most common)- Coxsackievirus A- Echovirus- Other non-polioviruses

Among these, Coxsackievirus B is the most frequently identified virus in cases of epidemic pleurodynia. These viruses are transmitted through respiratory droplets or fecal-oral routes, making the condition contagious and capable of spreading within communities.

Mechanism of Infection

When a person is exposed to one of these enteroviruses, the virus incubates in the intestines for a period of time before spreading to other areas of the body. Coxsackievirus B, for instance, typically incubates for approximately one week before spreading to the skeletal muscles and central nervous system. Once the virus reaches the chest and abdominal muscles, it causes inflammation in the muscle tissue (myositis), which results in the severe, intermittent pain characteristic of epidemic pleurodynia.

Symptoms and Clinical Presentation

The symptoms of epidemic pleurodynia typically develop suddenly, often just days after exposure to the virus. The illness is characterized by a constellation of flu-like symptoms combined with distinctive muscular pain.

Primary Symptoms

The hallmark symptom of epidemic pleurodynia is severe, frequently intermittent pain that begins suddenly in the epigastrium (upper abdomen), lower abdomen, or lower anterior chest region. This pain is often pleuritic in nature, meaning it worsens with breathing or movement. The pain typically:

– Occurs in bouts lasting 15 to 30 minutes- Is often localized to one side of the body- Alternates between sharp stabbing sensations and dull aching between episodes- May be accompanied by tenderness and swelling of the involved truncal muscles

Associated Symptoms

In addition to chest and abdominal pain, patients commonly experience:

– Fever (present in approximately 97% of cases)- Sore throat and upper respiratory symptoms (seen in 85% of patients)- Headache (occurring in about 50% of cases)- Malaise and general feeling of unwellness- Nausea, vomiting, and diarrhea (in approximately 50% of cases)- Dermatitis or rash (in about 25% of cases)- Testicular pain (in approximately 10% of male cases)

Course of Illness

The typical course of epidemic pleurodynia shows the following timeline:

– Symptoms usually subside within 2 to 4 days- However, symptoms may recur within days and persist or recur intermittently for several weeks- Some patients experience the condition lasting up to three weeks- Relapses during the weeks following the initial episode are a characteristic feature of this disease

In rare cases, epidemic pleurodynia may be associated with complications such as aseptic meningitis, orchitis (inflammation of the testicles), or myopericarditis (inflammation of the heart muscle and surrounding membrane).

Diagnosis of Epidemic Pleurodynia

Diagnosing epidemic pleurodynia involves a combination of clinical assessment and, when necessary, laboratory testing. The diagnostic approach varies depending on the clinical context and the presence of known outbreaks in the community.

Clinical Diagnosis

In many cases, diagnosis can be based on clinical presentation alone, particularly when there is a known outbreak of the condition in the area. A child presenting with unexplained severe pleuritic or abdominal pain during an epidemic of epidemic pleurodynia may be diagnosed based on history and physical examination alone. However, in other situations where symptoms are less clear or when other serious conditions need to be ruled out, additional testing may be required.

Differential Diagnosis Considerations

Because the main symptom of epidemic pleurodynia is pain in the chest or upper abdomen, additional testing may be required to exclude other potential serious causes, including:

– Cardiac conditions and heart disease- Pulmonary conditions affecting the lungs- Acute surgical abdomen- Other causes of pleurisy

Laboratory Diagnosis

When laboratory confirmation is necessary, several methods can be used to identify the causative virus:

– Viral culture from respiratory or stool samples- Blood tests to detect antibodies to the virus (serology)- Demonstration of seroconversion (rising antibody titers between acute and convalescent samples)- Serum creatine kinase measurement, which is usually elevated due to muscle inflammation

A definitive diagnosis of epidemic pleurodynia is particularly important for suspected cases in vulnerable populations such as newborn babies or pregnant women, as these groups may require specific interventions.

Treatment and Management

Since epidemic pleurodynia is caused by a viral infection, it cannot be treated with antibiotics. Instead, treatment focuses on relieving symptoms and supporting the body’s natural recovery process.

Symptomatic Management

The primary approach to treating epidemic pleurodynia involves managing pain and other symptoms:

Pain Management

Over-the-counter pain medications are the first line of treatment:

– Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Motrin, Advil) and naproxen- Acetaminophen (Tylenol)- These medications help ease pain and reduce inflammation of the affected muscles

Important Note for Pediatric Patients: Aspirin should never be given to children with viral infections, as this can cause a severe and potentially life-threatening condition called Reye’s syndrome.

Additional Comfort Measures

Beyond medication, patients can find relief through:

– Application of heat to the affected muscles- Rest and avoiding strenuous physical activity- Gradual return to normal activities as symptoms improve

Advanced Pain Management

In certain cases where pain is particularly severe and resistant to standard treatment, healthcare providers may consider:

– Peripheral nerve blockers- Intercostal injections of 2% xylocaine with normal saline to directly relieve symptoms in specific cases

Special Populations

Newborn Infants

Newborn babies are at particular risk for developing severe illness if exposed to the viruses that cause epidemic pleurodynia. If it is suspected that a newborn has been exposed to the virus, treatment with immunoglobulin is recommended. Immunoglobulin is a purified protein extracted from blood that contains antibodies capable of fighting the infection and reducing its severity.

Pregnant Women

Pregnant women with suspected epidemic pleurodynia should receive careful medical evaluation and monitoring to ensure both maternal and fetal well-being.

Prognosis and Recovery

The prognosis for epidemic pleurodynia is generally excellent. The condition is self-limited, meaning it resolves on its own with time and supportive care. Most patients experience significant improvement within 2 to 4 days, though some may have lingering symptoms or recurrent episodes for several weeks. There are no long-term complications or chronic effects from epidemic pleurodynia, and full recovery is the expected outcome for all patients.

Prevention and Transmission

Epidemic pleurodynia is a contagious condition spread through respiratory droplets and fecal-oral routes. Prevention measures include:

– Practicing good hand hygiene, particularly after using the bathroom and before eating- Covering mouth and nose when coughing or sneezing- Avoiding close contact with infected individuals- Maintaining distance during known outbreaks- Disinfecting commonly touched surfaces

Frequently Asked Questions

Q: Is epidemic pleurodynia life-threatening?

A: No, epidemic pleurodynia is not life-threatening. While it causes severe pain and discomfort, the condition is self-limited and resolves completely with appropriate supportive care. Serious complications are rare.

Q: How long does epidemic pleurodynia typically last?

A: Most patients experience symptom improvement within 2 to 4 days. However, symptoms may recur or persist intermittently for up to several weeks in some cases.

Q: Can antibiotics treat epidemic pleurodynia?

A: No, antibiotics cannot treat epidemic pleurodynia because it is a viral infection, not a bacterial one. Treatment focuses on symptom relief through pain management and supportive care.

Q: What is the difference between epidemic pleurodynia and pleurisy?

A: Pleurisy is inflammation of the pleural membranes surrounding the lungs, while epidemic pleurodynia is inflammation of the chest and abdominal muscles caused specifically by enteroviruses. Epidemic pleurodynia is sometimes called viral pleurodynia or pleurisy when it results from viral infection.

Q: Who is most likely to develop epidemic pleurodynia?

A: While epidemic pleurodynia can occur at any age, it is most common in children and young adults. It occurs when these populations have exposure to the causative enteroviruses, particularly during outbreak periods.

Q: Is epidemic pleurodynia contagious?

A: Yes, epidemic pleurodynia is contagious and spreads through respiratory droplets and fecal-oral routes. Good hand hygiene and respiratory precautions are important to prevent transmission.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to renewcure,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete